Leucylleucine methyl ester is a drug potentially for the treatment of Graft-Versus-Host-Disease. References: Hsieh MH, Varadi G, Flomenberg N, Korngold R. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk. Biol Blood Marrow Transplant. 2002;8(6):303-15. PubMed PMID: 12108916.

纯度：≥98%

CAS：13022-42-9